glasses trends 2024 Archives

Visionary Women: Leaders in Eyewear and Eye Care

Friday, November 29 2024 | 08 h 54 min | Practice Management

by Shan Khan, RO In this issue, Optik spotlights two more remarkable women shaping the future of eye care in our industry Join us as we explore...

Moscot, Gelt frame on a beige background.

Fall 2024 Eyewear Trends: The Ultimate Guide to Seasonal Chic

Monday, November 11 2024 | 08 h 04 min | Frames Fashion

By Shan Khan, RO As the leaves start to change and we cozy up for the fall season, it's time to update your patients on the latest eyewear trends...

Elegant GIGI STUDIOS glasses with tortoiseshell frames on a clear, shattered glass surface with green foliage accents

The Art of the Frame: Unveiling GIGI STUDIOS’ Fashion‑Forward Vision

Friday, March 22 2024 | 08 h 46 min | Frames Fashion

By Mark Matthews GIGI STUDIOS is not just an eyewear brand; it's a manifesto of individuality and creativity With a 60-year family legacy, the...

Model showcasing contemporary sunglasses with a blurred building in the background

Flaunt the Frame New Fashion Show Series: A Spectacle of Style at Vision Expo East

Wednesday, March 20 2024 | 13 h 05 min | Frames Fashion

By Mark Matthews In a dazzling fusion of fashion and function, the upcoming "Flaunt The Frame™" independent eyewear fashion show series,...

Fabrics and colour swatches that include Peach Fuzz and similar shades.

Embracing Elegance: Pantone Color of 2024 in Eyewear Trends

Monday, March 18 2024 | 15 h 00 min | Frames Fashion

By Shan Khan As the fashion world continues to evolve, eyewear enthusiasts and eye care professionals (ECPs) alike eagerly awaited the unveiling...

Optometry Giving Sight Announces 2024 Grant Winners

This year, 16 grants totaling almost $1 million USD have been awarded to 15 organizations for projects that will help eradicate uncorrected refractive error globally.

Learn More

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. logos

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

The Centre for Eye and Vision Research (CEVR) and SCOPE Health Inc. have announced the signing of a Memorandum of Understanding (MoU) to establish a collaborative partnership focused on developing innovative technologies for dry eye disease and other ocular surface conditions.

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Works in BMJ Open Ophthalmology, Ophthalmic and Physiological Optics, and Translational Vision Science & Technology Focus on Efficacy, Vision, and Contrast Theory

Optometry Giving Sight Announces 2024 Grant Winners

This year, 16 grants totaling almost $1 million USD have been awarded to 15 organizations for projects that will help eradicate uncorrected refractive error globally.

Learn More

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Works in BMJ Open Ophthalmology, Ophthalmic and Physiological Optics, and Translational Vision Science & Technology Focus on Efficacy, Vision, and Contrast Theory

Optometry Giving Sight Announces 2024 Grant Winners

This year, 16 grants totaling almost $1 million USD have been awarded to 15 organizations for projects that will help eradicate uncorrected refractive error globally.

Learn More

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

A new study published in The Lancet shared results from a Phase 1/2 clinical trial testing a one-time anti-VEGF gene therapy for wet age-related macular degeneration (wet AMD).

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CooperVision recently hosted an Innovation Tour for 20 eye care professionals from across Canada at its state-of-the-art, LEED® certified manufacturing facility located in San José, Costa Rica.

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Works in BMJ Open Ophthalmology, Ophthalmic and Physiological Optics, and Translational Vision Science & Technology Focus on Efficacy, Vision, and Contrast Theory

Tag: glasses trends 2024

Visionary Women: Leaders in Eyewear and Eye Care

Fall 2024 Eyewear Trends: The Ultimate Guide to Seasonal Chic

The Art of the Frame: Unveiling GIGI STUDIOS’ Fashion‑Forward Vision

Flaunt the Frame New Fashion Show Series: A Spectacle of Style at Vision Expo East

Embracing Elegance: Pantone Color of 2024 in Eyewear Trends

Featured Posts

Optometry Giving Sight Announces 2024 Grant Winners

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Optometry Giving Sight Announces 2024 Grant Winners

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Optometry Giving Sight Announces 2024 Grant Winners

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™

Optometry Giving Sight Announces 2024 Grant Winners

Gene Therapy for Wet AMD: Phase 1/2 Clinical Trial Results

CooperVision Hosts Canadian ECPs for Innovation Tour in Costa Rica

CEVR and SCOPE Health Sign a MoU to Develop and Commercialize Novel Product Technologies for the Treatment of Dry Eye and Ocular Surface Conditions

Three New Peer Reviewed Papers Expand Myopia Management Evidence for SightGlass Vision Diffusion Optics Technology™